HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplantation

Clinical trial NCT04464889 · WITHDRAWN

Trial details

NCT number: NCT04464889
Sponsor: Medigene AG
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Lymphoid Leukemia Myelodysplastic Syndromes Myeloproliferative Disorders Chronic Myeloid Leukemia Myelofibrosis Multiple Myeloma Malignant Lymphoma

Start date: 2020-07-02
Primary completion: 2023-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.